Aprocitentan

Jeraygo

12.5 MG TabletCanadaAuthorised

Open in the registerAsk Osler about it

In other countries

The same active substances on other registers, the same brand first.

JeraygoEuropean Union · Idorsia Pharmaceuticals Deutschland GmbHSame brand
JeraygoCroatiaSame brand
JERAYGO 12,5 mg filmomhulde tablettenNetherlands · Filmomhulde tablet · Idorsia Pharmaceuticals Deutschland GmbHSame brand
JERAYGO 25 mg filmomhulde tablettenNetherlands · Filmomhulde tablet · Idorsia Pharmaceuticals Deutschland GmbHSame brand
TryvioUnited States · 12.5MG · tablet · IdorsiaSame form

Documents

The official texts, at the regulator.

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.

Discover Osler

Aprocitentan

Jeraygo

12.5 MG TabletCanadaAuthorised

Open in the registerAsk Osler about it

In other countries

The same active substances on other registers, the same brand first.

Documents

The official texts, at the regulator.

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.

Discover Osler

Register entry

Health Canada

Sources and licences

Compiled by Prognia from the public register below; the register’s text is the official one.

Health Canada, Canada

Health Canada, Drug Product Database, drugproduct API, entire response observed 2026-10-10T15:12:07.336870+00:00; native facts projected by Prognia.

Licence: Open Government Licence Canada · Added 13 Oct 2026

Report an error or request removalCorrections from the holder or the register are welcome.

Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.

At a glance

Active substance: Aprocitentan
Strength: 12.5 MG
Dosage form: Tablet
Route: Oral
Register: Canada (Health Canada)
Status: Authorised
Status in the register: Approved
Registration: DIN 02563983
Marketing authorisation holder: Idorsia Pharmaceuticals LTD
ATC code: C02KN01
Group: Cardiovascular system
Supply: PRESCRIPTION